Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has informed that that one of the wholly owned subsidiaries of its subsidiary company, Taro Pharmaceutical Industries has agreed to acquire by way of purchase of all outstanding shares of Aquinox Pharmaceuticals (Canada) Inc., a corporation organized and existing under the laws of the Province of British Columbia that carries on the business of research and development of pharmaceutical products for purposes of their commercialization. The disclosures pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, are attached as per ‘Annexure A’.

The above information is a part of company’s filings submitted to BSE.